Nasal influenza vaccine composition

A technology of influenza vaccine and composition, applied in the direction of drug combination, microorganism, drug delivery, etc., to achieve the effects of small side effects, long-term distribution, and induction of immune response

Inactive Publication Date: 2019-07-23
JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INST OF INFECT IOUS DISEASES +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] As mentioned above, it is urgently desired to develop and put into practical use a nasal administration type vaccine as a next-generation influenza vaccine based on existing influenza vaccines administered subcutaneously or intramuscularly. There are various problems in the face of practical application, such as the toxicity of the adjuvant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nasal influenza vaccine composition
  • Nasal influenza vaccine composition
  • Nasal influenza vaccine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064]

Embodiment 2

[0066]

Embodiment 3

[0068]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a nasal mucosal spray delivery type influenza vaccine composition which is characterized in that the composition comprises a gel base including an influenza virus inactivated whole particle antigen and a carboxyl vinyl polymer but does not comprise an adjuvant.

Description

[0001] This application is a divisional application of the original application of the PCT international application PCT / JP2013 / 078721 with the international filing date of October 23, 2013, which entered the Chinese national phase with the application number 201380068031.4 and the invention name "nasal influenza vaccine composition" . technical field [0002] The invention relates to a nasal mucosa spray administration type influenza vaccine composition. Background technique [0003] Influenza is an acute respiratory infectious disease caused by influenza virus, especially in winter, which is prevalent every year. In addition, sometimes it becomes a worldwide pandemic, and there are many cases where the disease becomes severe and leads to death. Influenza is known to have a certain preventive effect through influenza vaccination, and the vaccination is widely performed before the epidemic period. [0004] In Japan, influenza vaccines are approved only for subcutaneous adm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/145A61K9/06A61K47/32A61P31/16
CPCA61K9/06A61K47/32A61K9/0043A61K2039/543C12N2760/16134A61K2039/5252A61K2039/55555C12N2760/16234A61K39/12A61K39/145A61P31/00A61P31/16A61P37/04A61K47/30C12N7/00C12N2760/16121
Inventor 长谷川秀树铃木忠树相内章上下泰造宫崎隆
Owner JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INST OF INFECT IOUS DISEASES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap